首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Current Pharmaceutical Analysis

Current Pharmaceutical Analysis杂志,由Bentham Science Publishers B.V.出版,于2005年创刊,Quarterly,出版语言English,ISSN:1573-4129,E-ISSN:1875-676X。

投稿咨询
Current Pharmaceutical Analysis
Current Pharmaceutical Analysis
Current Pharmaceutical Analysis
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
4区
影响因子
3.6
CiteScore
2.7
期刊收录
SCI、SCIE

Current Pharmaceutical Analysis(中文译名:《当前的药物分析》),ISSN:1573-4129,EISSN:1875-676X,是Bentham Science Publishers B.V.出版的国际性学术期刊,创刊于2005年,以Quarterly形式稳定发行,2026年总发文量约40篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.6,2025年期刊CiteScore为2.7,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Current Pharmaceutical Analysis长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约2月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDIndia、Egypt、Turkey、Iran、Saudi Arabia、Brazil等为核心发文国家与地区;CAIRO UNIVERSITYWENZHOU MEDICAL UNIVERSITY、KING SAUD UNIVERSITY、ANKARA UNIVERSITY、ISLAMIC AZAD UNIVERSITY、SHANDONG UNIVERSITY、NANJING UNIVERSITY OF CHINESE MEDICINE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 128 / 356

64.2

学科:PHARMACOLOGY & PHARMACY SCIE Q3 227 / 356

36.38


中国学者近期发文

1
HPLC-DAD quantitative analysis via multiomics elucidated the potential HSP90AB1-targeted mechanism of the Scutellaria-Coptis herb pair in high-risk prostate cance

Author:Wu, Jiacheng; Zhai, Baoqian; Zong, Yang; Wang, Hongzhi; Chang, Pingan; Yao, Wentao; Wang, Xiaolin; Huang, Yuhua

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 3, pp. 273-283. DOI: 10.1016/j.cpan.2026.03.006

2
Jiawei Guilu Erxian Decoction enhances CD8'T-cell activation and cytotoxicity via JNK/c-JUN activation to suppress non-small cell lung cancer tumor growth in viv

Author:Ke, Bin; Zhong, Hai; Chen, Xiaofei; Chen, Ke; Wang, Shujing; Li, Liuyinuo; Li, Quanfeng; Li, Jianjun; Shi, Lin

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 3, pp. 197-207. DOI: 10.1016/j.cpan.2026.03.002

3
Screening the effective metabolites of Mosla soochowensis Matsuda on LPSinduced inflammation in RAW264.7 cells by integrated LC-triple TOF-MS/ MS and network pharmacolog

Author:Qiu, Hailong; Liu, Xun; Tan, Rulan; Hu, Chenqian; Zuo, Tongwen; Fei, Chenghao; Jiang, Dongjing; Wang, Huifang; Xu, Xiaojun

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 3, pp. 219-232. DOI: 10.1016/j.cpan.2026.03.004

4
Pharmacological basis and antifibrotic potential of Zhuang medicine huanggen in hepatic and pulmonary fibrosi

Author:Chen, Minqi; Hou, Wanchao; Lu, Jinhua; Liu, Qianhan; Zeng, Wanrong; Hao, Erwei; Hou, Xiaotao; Du, Zhengcai; Deng, Jiagang; Yu, Kai

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 3, pp. 211-218. DOI: 10.1016/j.cpan.2026.02.001

5
Advances in traditional Chinese medicine for the treatment of acute radiation-induced oral mucositis: A review from clinical efficacy to pharmacological and analytical insight

Author:Shao, Zhouxiang; Liang, Haina; Weng, Weian; Yu, Xiaoxiao

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 2, pp. 149-156. DOI: 10.1016/j.cpan.2026.01.003

6
Effects of different doses of esketamine combined with propofol on gastrointestinal endoscopy in elderly patient

Author:Ni, Xin; Zhang, Xinxin; Jiang, Qing; Gao, Hongmei; Gu, Jiaqiu; Zhu, Yijun

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 2, pp. 134-139. DOI: 10.1016/j.cpan.2025.11.004

7
Exploring the potential anti-hepatocarcinoma mechanism of Ruangan Lidan Decoction through UHPLC-Q-TOF-MS/MS analysis and network pharmacology approache

Author:Huang, Liyin; Si, Tao; Liang, Ting; Yu, Peishan; Dun, Linglu; Zhang, Mingmin; Chen, Haihui

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 1, pp. 49-61. DOI: 10.1016/j.cpan.2025.10.004

8
A narrative literature review on revolutionizing traditional Chinese medicine: Exploring the potential of spectral imaging technolog

Author:Tang, Zhihua; Tan, Xinghua; Yu, Lushan; Zhang, Ke

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 1, pp. 86-98. DOI: 10.1016/j.cpan.2025.12.003

9
Trifluridine/tipiracil exhibits potent antitumor activity in triple-negative breast cancer by targeting SKP2 and inducing cell cycle arrest and apoptosis?

Author:Hu, Erwei; Wang, Yiwei; Chen, Ge; Xu, Chongyang; Liu, Suhui; Zou, Yufeng; Luo, Xuan; Gong, Yu

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 1, pp. 35-43. DOI: 10.1016/j.cpan.2025.12.005

10
Integrating metabolomics, DPPH assay, and literature mining for quality marker prediction and the establishment of a quality control strategy for Ampelopsis grossedentat

Author:Fan, Xiao-Su; Yuan, Zheng-Ying; Qin, Yu-Shan; Lu, Dong-Mei; Zhao, Xin-Yu; Gao, Si-Wei; Qin, Xue; Zhu, Rui-Yu; Wen, Yong-Qiang; Shen, Fang-Ke; Hu, Ping; Gu, Ming-Hua

Journal: CURRENT PHARMACEUTICAL ANALYSIS. 2026; Vol. 22, Issue 1, pp. 74-85. DOI: 10.1016/j.cpan.2025.12.008


在线咨询

Current Pharmaceutical Analysis

国际简称:CURR PHARM ANAL参考译名:当前的药物分析

年发文量:40 CiteScore:2.7 是否预警:否 Gold OA文章占比:23.96% 研究类文章占比:92.50%

杂志社联系方式:BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR

Current Pharmaceutical Analysis